Glioblastoma-derived EVs carry CXCR4 monomers and dimers, as well as VEGF. Treatment of endothelial cells with these EVs promotes cell proliferation, motility and tube formation compared to control EVs. The gene discussed is VEGFA; the disease is glioblastoma.